Apremilast for the Treatment of Moderate to Severe Plaque Psoriasis : A Critique of the Evidence

Hinde, Sebastian orcid.org/0000-0002-7117-4142, Wade, Ros orcid.org/0000-0002-8666-8110, Palmer, Stephen orcid.org/0000-0002-7268-2560 et al. (2 more authors) (2016) Apremilast for the Treatment of Moderate to Severe Plaque Psoriasis : A Critique of the Evidence. PharmacoEconomics. 587–596. ISSN 1179-2027

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © Springer 2016. This is an author-produced version of the published paper. Uploaded in accordance with the publisher’s self-archiving policy. Further copying may not be permitted; contact the publisher for details
Dates:
  • Published: 2016
  • Published (online): 28 January 2016
Institution: The University of York
Academic Units: The University of York > Faculty of Social Sciences (York) > Centre for Health Economics (York)
The University of York > Faculty of Social Sciences (York) > Centre for Reviews and Dissemination (York)
Depositing User: Pure (York)
Date Deposited: 03 Feb 2016 10:25
Last Modified: 13 Nov 2019 09:50
Published Version: https://doi.org/10.1007/s40273-016-0382-3
Status: Published
Refereed: Yes
Identification Number: https://doi.org/10.1007/s40273-016-0382-3

Download

Filename: Apremilast_for_psoriasis_PharmacoEconomics_resubmission_clean.docx

Description: Apremilast for psoriasis PharmacoEconomics resubmission clean

Share / Export

Statistics